Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Dolasetron now available in U.S.

Feb. 25, 1998

Lead compound from ABS shows promise for neurodegenerative disorders

Feb. 25, 1998

Another market introduction for Aricept

Feb. 25, 1998

Biogen sets up Canadian office to promote local development of Avonex

Feb. 25, 1998

NOS inhibition with L-NMMA reduces CBF in humans

Feb. 25, 1998

C. pneumoniae antibody titers correlated to stroke and cerebral ischemia

Feb. 25, 1998

T Cell Sciences receives patent on new compound

Feb. 25, 1998

Apollo licenses technologies from U. of Florida

Feb. 24, 1998

Positive phase I results reported for TCAR product for MS

Feb. 24, 1998

CPMP recommends European approval of Exelon

Feb. 24, 1998

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 10, 2025
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...